CPPIB Chief Mark Machin Exits Amid Vaccine Uproar

The CEO of Canada’s largest pension fund traveled to the Middle East to get a shot. The plan’s credit head, John Graham, replaces him.

Mark Machin

The head the Canada Pension Plan Investment Board (CPPIB) has stepped down in the wake of his journey to the Middle East to receive a vaccination for COVID-19.

CEO Mark Machin, 54, traveled to the United Arab Emirates (UAE) to get the shot earlier this month, as Canada’s rollout of its vaccination program has lagged. Canada’s largest pension fund (US$379 billion) named John Graham, the fund’s head of credit investments, as Machin’s successor.

“After discussions last evening with the board, Mr. Machin tendered his resignation and it has been accepted,” the fund said in a statement. The statement said he had traveled personally to get the vaccine.

The Wall Street Journal, which broke the story, quoted a CPPIB spokesman saying Machin made the trip “for deeply personal reasons” and that he used “zero influence” to obtain the dose. The paper wrote that he is awaiting his second shot, using the vaccine from Pfizer and BioNTech.

Want the latest institutional investment industry
news and insights? Sign up for CIO newsletters.

The British-born Machin, who had worked as a Goldman Sachs investment banker in Hong Kong for two decades, joined CPPIB as head of its Asia operations in 2012. The fund promoted him to CEO in 2016. As the leader of one of the world’s largest pension programs, he has been listed as one of CIO’s Power 100.

The office of Canadian Finance Minister Chrystia Freeland criticized Machin’s trip as “very troubling,” adding that the government discouraged Canadians from traveling abroad, according to the Globe and Mail.

Before joining CPPIB in 2008, new CEO Graham spent nine years at Xerox Innovation Group in research and strategy jobs. 

Related Stories:

2018 Power 100 – Mark Machin

Canada’s Machin Staying the Course with China Despite Tension

Canadian Pension Board Shakes Up Leadership

Tags: , , , , , ,

Post-COVID Stock Picks: Morgan Stanley Highlights Its Recovery Plays

McDonald’s, Exxon, and Lamar Advertising are on their winners’ list.


The stock market took a beating Thursday as rising 10-year Treasury yields spooked investors. But regardless of where the market goes next—and it has had a way of bouncing back from periodic selloffs—Morgan Stanley has a long-range plan for stock picking.

The investment house has identified under-loved stocks that should do well in a post-pandemic world, using a bunch of metrics it calls “quantamental.” In other words, it employs math-heavy methods, such as comparing valuations of stocks before the onset of the coronavirus and today, and also consults its analysts on various businesses.

“With the market broadly pricing a post-COVID-19 rebound, we look for the alpha opportunities where COVID-related benefits and damage appear mispriced,” the firm’s researchers wrote in a report.

Morgan Stanley does bring some cred to this exercise. Last spring, it correctly predicted a big turnaround from the pandemic plunge.

Never miss a story — sign up for CIO newsletters to stay up-to-date on the latest institutional investment industry news.

Some of the winners already are doing fairly well in a time of lockdowns and avoidance of much in-person activity such as shopping. UnitedHealth Group has enjoyed a 28% share boost over the past 12 months. For the fourth quarter of 2020, the health insurance giant reported a $2.52 earnings per share return, 12 cents above the analysts’ consensus, according to FactSet.

McDonald’s is another one that hasn’t done too, too badly. The stock is up just 8.6% over the past year. Same-store sales fell 1.6% in the fourth period, but the company has given optimistic future guidance. And it has floated several new products, like avocado toast and Beyond Meat sandwiches.

An example of a beaten-down stock that Morgan Stanley thinks will rally up ahead: Exxon Mobil. Indeed, the oil industry has gotten a boost for its shares as petroleum prices have climbed back. Exxon, which reported losses last year, has had a welcome stock surge since its November low. Meantime, it continues to be a target of environmental-minded investors.

Another kicked-around winner is Lamar Advertising, whose stock now is just 3% ahead of 12 months before the pandemic. The billboard company suffered from a shrinking of advertising at the outset of the pandemic. After bottoming out in last year’s third quarter, Lamar’s revenue and earnings began to perk up. Profits for the fourth quarter, however, still were off 33% from the largely pre-virus first period.

No surprise, among the 30 industries that Morgan Stanley examined, those with an online bent had the best prospects. “Increased digital consumption, distribution, and customer interaction,” the report said, “stand out as among the more durable trends.”

The study is the product of a collaboration that’s hunting for undervalued stars. Morgan Stanley’s quantitative research group joined forces with its fundamental equity analysts to spotlight stocks that could pleasantly surprise investors as an economic recovery gathers momentum.

“We’re bullish on the economic recovery, but think it’s largely in the price of the major index stock picking is key,” the research note indicated.

In search of potential winners, it compared earnings estimates with pre-pandemic ones to discover which companies had low expectations. The sectors with the most underappreciated stocks, by this method, were energy, financials, machinery, and media. 

Then the analysts weighed in to ensure that this system’s findings made sense. “The market is pricing some degree of structural impairment, but we see upside from a cyclical recovery and/or wallet share reversion,” the note declared.

Related Stories:

CalSTRS Lambasts Exxon’s Red Ink and Carbon Capture Venture

Morgan Stanley: Buy Inflation-Sensitive Stocks

Stocks Now Are the Spittin’ Image of 2009, Morgan Stanley Strategist Says

Tags: , , , , , , , ,

«